Events

Past Events

Seven Springs, PA
|
Feb 13- Feb 15, 2019

Immunotherapy: the force awakens.

With keynote presentations from Ivan M. Borrello, MD and Cynthia L. Sears, MD. For more information or to register, visit www.TRCCC.org

New York City, USA
|
Feb 6- Feb 8, 2019

CIMT is pleased to offer its members a 20% discount to attend the 5th annual Immuno-Oncology 360° meeting, at the Crowne Plaza Times Square, New York City, USA. The 5th annual Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, including the most up-to-date research, data and progress, to help foster collaboration across all IO stakeholders and transform the way cancer is treated. For more information, please go to http://theconferenceforum.org/...Register and use discount code CIMT to receive 20% off.

Maui, HI
|
Jan 30- Feb 2, 2019

The 2019 Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months, and feature expected advances that you and your patients will likely see in the upcoming year.

London, UK
|
Jan 30- Jan 31, 2019

Now in its 3rd year, the CAR-T Congress Europe in London brings together stakeholders across industry and academia to address the critical challenges head-on and stimulate discussion to identify the unmet needs. Novartis & Kite will share insights on how to accelerate approval in the European market. Get a chance to meet John Maher from King’s College and network with leaders from Novartis, Torque Therapeutics, Cellectis, Celyad, Servier, Gadeta and Bluebirdbio.

Vancouver, Canada
|
Jan 20- Jan 24, 2019

Scientific Organizers: Lélia Delamarre, Robert A. Seder and Nina Bhardwaj. Organized in collaboration with Cancer Research UK.
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.

Cairo, Egypt
|
Jan 17- Jan 18, 2019

The 11th Breast, Gynecological and Immuno-oncology International Cancer Conference (BGIICC) is the only conference specialized in breast gynecological cancers in Africa and the Middle-East. The 2019 Scientific Program is designed to give a good platform for the exchange of experience on cancers and to outline the actual status of the problems relating to the Breast and Gynecological cancers, with discussion of the prospects in the context of the most recent international trends and initiatives for the treatment.

Miami, FL
|
Nov 27- Nov 30, 2018

This AACR special conference is designed to integrate multi-disciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. This year’s program will expand our knowledge of the microbiome; metabolic regulation; oncogenic, myeloid, and vascular pathways; and targeted therapies. These world-renowned oncologists and scientist will offer new insights on systems biology, checkpoint, combination therapies, and molecular targets.

San Diego, CA
|
Oct 11- Oct 12, 2018

Due to the success of the UK Advances in Immuno-Oncology event, Oxford Global are expanding this event to the USA. The USA Congress is the first of its kind and will feature over 20 presentations from leading heads of the Pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate.

Topic discussion ranges across a variety of therapeutic strategies, from CAR T cell therapies to microbiome in Immuno-Oncology and from assays and modelling in Immuno-Oncology to NK cell-based therapeutics.

ACIR members wanting to attend this Congress (Academic and Industry attendees only) are eligible for a 20% discount. Contact Danielle Dalby today at d.dalby@oxfordglobal.co.uk and quote IMMUNO20.

New York, NY
|
Sep 30- Oct 3, 2018

The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to present this program. It will feature talks from more than 60 leaders in the field, covering all areas of inquiry in cancer immunology and immunotherapy. The session topics will include Regulating T Cells and Their Response to Cancer; Tackling the Tumor Microenvironment- beyond T Cells; Genetically Engineered T Cells; Maintenance of Immune Balance: Effects of Targeted and Immune Therapies; Novel Vaccine Platforms and Combinations; Mutational Analysis and Predicting Response to Immunotherapy; Convergence of Technology and Cancer Immunotherapy; Microbiome and Metabolism.

*Update: The ACIR team attended several talks at the conference. You can read our coverage here.

Sao Paulo, Brazil
|
Sep 27- Sep 29, 2018

In cooperation with LAGOS, the conference will present an overview of state-of-the-art translational cancer research. It will explore the latest discoveries in targeted therapies and drug resistance, cancer immunology, drug discovery, and the most common cancers in the region. The session topics will include Immune Checkpoints and The Microbiome and Cancer.

San Diego, CA
|
Sep 17- Sep 18, 2018

Conference deals with the diagnosis, prevention, and treatment of diseases of the organ specific cancers and including the latest techniques. It is an event designed for International medical health professionals and oncologists to facilitate the dissemination and application of research findings related to Cancer. It provides two days of robust discussions on methods and strategies related to management and quality improvement of Cancer therapy, Tumor Biomarkers as well as explore new ideas and concepts on a global scale and the topics include breast cancer, leukaemia, bone cancer, lung cancer, prostate cancer, thyroid cancer, blood cancer, colon cancer and cervical cancer.

Madrid, Spain
|
Sep 13- Sep 15, 2018

The International Conference on Lymphocyte Engineering (ICLE 2018) will provide a dedicated platform to advance research, clinical translation and treatment in immuno-gene therapy. ICLE brings together immunotherapy with cell and gene therapy to foster interdisciplinary collaborations, deepening the connection between basic and clinical research across related disease specialties: oncology, pathogenic diseases, autoimmunity, immunodeficiencies and others.

Boston, MA
|
Aug 27- Aug 31, 2018

Join over 600 thought leaders at industry’s leading Immuno-Oncology event and learn about the latest research in a comprehensive 5-day, 12-track program, network and build lasting collaborations with an international mix of delegates from industry and academia, and gain actionable solutions to drive your organization’s next-generation immunotherapy programs.

Kyoto, Japan
|
Jul 10- Jul 12, 2018

The 6th JCA-AACR special joint conference will bring together basic scientists and clinical researchers from the United States and Japan, and around the world, to share the latest and more exciting developments in lung cancer research. Session topics will include: Novel Immunotherapy Strategies beyond PD-1/PD-L1; Primary and Acquired Mechanisms of Resistance to Immunotherapies; Tumor Microenvironment and Implications for Treatment.

Amsterdam, Netherlands
|
Jun 30- Jul 3, 2018

The theme of the Congress is ‘From Fundamental Insight to Rational Cancer Treatment’, covering the journey of discovery and development ‘from bench to bedside’. The Congress will feature world-class speakers discussing the most innovative current research topics, including a special education track aimed at clinicians. As well as high-profile plenary sessions, the program offers parallel symposia, allowing participants to build their own scientific program according to their interests.

Basel Switzerland
|
Jun 24- Jun 26, 2018

During this Cell Symposium, you will hear about the latest advances in immunometabolism from physician-scientists, basic researchers and industry leaders. We will discuss how local and systemic metabolism are integrated at the cellular level to regulate immune cell function and we will focus on how novel insights into immunometabolism can be harnessed to advance and/or bolster therapeutic interventions in metabolic diseases, inflammation, autoimmunity, and cancer.

Chicago, IL
|
Jun 1- Jun 5, 2018

The Annual Meeting brings together more than 32,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.

London, Ontario, Canada
|
Jun 1- Jun 4, 2018

The Canadian Society for Immunology (CSI) is an organization that fosters and supports Immunology research throughout Canada. Founded in 1966, the society provides a focal point for Canadian Immunology by organizing an annual spring meeting that alternates between the west and the east of the country. One of the highlights of the annual meeting is the Cinader Award lecture, named in honor of Hardi Cinader, a founding member of CSI and its first president.

London, UK
|
May 24- May 25, 2018

The 3rd Annual Advances in Immuno-Oncology Congress features over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate.

Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.

Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more.

To register using ACIR 20% discount contact a.fernandez@oxfordglobal.co.uk and quote IMMUNO20

Chicago, IL
|
May 16- May 19, 2018

The mission of ASGCT to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.

Mainz, Germany
|
May 15- May 17, 2018

The CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT 2018 invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

Plenary sessions will range from pre-clinical research to clinical development on the topics of therapeutic vaccination, cellular therapy, improving immunity, tumor microenvironment, antibodies, regulatory research and immunoguiding. There will also be a poster exhibit and selected poster short talk sessions, as well as industry symposia and industry exhibits.

Boston, MA
|
May 8- May 9, 2018

The Cancer Microbiome Congress will bring together academics, physicians, senior pharma executives and biotechs to learn about the developments and network to improve treatments in future. The speakers presenting at the congress include David Cook from Seres Therapeutics, the first company to develop live microbial therapeutics and Vancheswaran "Deepak" Gopalakrishnan from MD Anderson who published the groundbreaking paper identifying how the gut microbiome influences responses to Anti-PD1-Therapy. See the agenda for the Congress here.

As a reader of ACIR, you will also benefit from an exclusive 10% discount, simply quote ACIR10 on registering.

Chicago, IL
|
Apr 14- Apr 18, 2018

Presentations at the Annual Meeting will cover the latest basic, translational, clinical, and prevention-focused research in the field, including important areas such as early detection, cancer interception, and survivorship in all populations. We will feature new sessions on cancer health disparities that have been inspired by one of the important AACR presidential initiatives. We will also be reprising a popular new feature from Annual Meeting 2017, “Unsolved Mysteries,” featuring provocative questions and their in-depth discussion by speakers and members of the audience.

*Update: The ACIR team attended several talks at the conference. You can read our coverage here.

Boston, MA
|
Mar 20- Mar 22, 2018

CAR-T Congress USA gathers 100+ thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors.

Hear from 25+ industry leaders including Ziopharm, Merck KGaA, GSK, Dana Farber, Celgene and leading research institutions to discuss the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, how to improve patient access, the development of an ‘off-the-shelf’ product and commercializing this new cell therapy.

As a reader of ACIR, you will also benefit from an exclusive 10% discount, simply quote ACIR10 on registering.

*Update: The ACIR team attended several talks at the conference. You can read our coverage here.

Berlin, Germany
|
Mar 19- Mar 21, 2018

The program will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring, and biomarker development.

At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals, and the pharmaceutical industry.